Lantheus (LNTH) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $99.99, -0.01% vs the prior close of $100.00.
- Volume 866.50K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
LNTH ends flat (-0.0%) to $99.99, 4 down days in a row. Closed at $99.99, -0.01% vs the prior close of $100.00. Day range $99.95–$100.18, opened at $100.05.
LNTH daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — LNTH ends flat (-0.0%) to $99.99, 4 down days in a row
- Closed at $99.99, -0.01% vs the prior close of $100.00. Day range $99.95–$100.18, opened at $100.05.
- Volume was 866.50K shares, 0.7x its 50-day average of 1.22M.
- Price is -0.4% vs its 50-day average ($100.40) and +11.6% vs its 200-day average ($89.59).
- 52-week range $50.15–$111.86; today's close sits at 81% of that range, 10.6% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — LNTH ends flat (-0.0%) to $100.00, 3 down days in a row
- Closed at $100.00, -0.02% vs the prior close of $100.02. Day range $99.92–$100.23, opened at $100.06.
- Volume was 936.70K shares, 0.7x its 50-day average of 1.30M.
- Price is -0.4% vs its 50-day average ($100.43) and +11.8% vs its 200-day average ($89.43).
- 52-week range $50.15–$111.86; today's close sits at 81% of that range, 10.6% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — LNTH ends flat (-0.1%) to $100.02
- Closed at $100.02, -0.09% vs the prior close of $100.11. Day range $99.99–$100.28, opened at $100.20.
- Volume was 1.54M shares, 1.1x its 50-day average of 1.43M.
- Price is -0.4% vs its 50-day average ($100.45) and +12.1% vs its 200-day average ($89.26).
- 52-week range $50.15–$111.86; today's close sits at 81% of that range, 10.6% below the 52-week high.
Oct 12, 2026 — LNTH ends flat (-0.0%) to $100.11
- Closed at $100.11, -0.04% vs the prior close of $100.15. Day range $100.06–$100.36, opened at $100.10.
- Volume was 951.60K shares, 0.7x its 50-day average of 1.43M.
- Price is -0.4% vs its 50-day average ($100.48) and +12.4% vs its 200-day average ($89.10).
- 52-week range $50.15–$111.86; today's close sits at 81% of that range, 10.5% below the 52-week high.
Oct 9, 2026 — LNTH ends flat (+0.0%) to $100.15
- Closed at $100.15, +0.03% vs the prior close of $100.12. Day range $100.06–$100.40, opened at $100.06.
- Volume was 973.50K shares, 0.7x its 50-day average of 1.44M.
- Price is -0.3% vs its 50-day average ($100.47) and +12.6% vs its 200-day average ($88.93).
- 52-week range $50.15–$111.86; today's close sits at 81% of that range, 10.5% below the 52-week high.
Oct 8, 2026 — LNTH ends flat (-0.1%) to $100.12
- Closed at $100.12, -0.06% vs the prior close of $100.18. Day range $100.08–$100.33, opened at $100.08.
- Volume was 520.10K shares, 0.4x its 50-day average of 1.46M — lighter than usual.
- Price is -0.4% vs its 50-day average ($100.48) and +12.8% vs its 200-day average ($88.77).
- 52-week range $49.67–$111.86; today's close sits at 81% of that range, 10.5% below the 52-week high.
Oct 7, 2026 — LNTH ends flat (+0.2%) to $100.18
- Closed at $100.18, +0.23% vs the prior close of $99.95. Day range $100.02–$100.33, opened at $100.20.
- Volume was 553.80K shares, 0.4x its 50-day average of 1.49M — lighter than usual.
- Price is -0.3% vs its 50-day average ($100.48) and +13.1% vs its 200-day average ($88.60).
- 52-week range $49.67–$111.86; today's close sits at 81% of that range, 10.4% below the 52-week high.
Oct 6, 2026 — LNTH ends flat (-0.2%) to $99.95
- Closed at $99.95, -0.24% vs the prior close of $100.19. Day range $99.89–$100.34, opened at $100.28.
- Volume was 730.10K shares, 0.5x its 50-day average of 1.49M — lighter than usual.
- Price is -0.6% vs its 50-day average ($100.53) and +13.0% vs its 200-day average ($88.42).
- 52-week range $49.67–$111.86; today's close sits at 81% of that range, 10.6% below the 52-week high.
Oct 5, 2026 — LNTH ends flat (+0.2%) to $100.19, 4 up days in a row
- Closed at $100.19, +0.23% vs the prior close of $99.96. Day range $99.95–$100.28, opened at $100.00.
- Volume was 658.90K shares, 0.4x its 50-day average of 1.49M — lighter than usual.
- Price is -0.5% vs its 50-day average ($100.69) and +13.5% vs its 200-day average ($88.25).
- 52-week range $49.67–$111.86; today's close sits at 81% of that range, 10.4% below the 52-week high.
- That makes 4 straight gains.
Oct 2, 2026 — LNTH rises 0.3% to $99.96, 3 up days in a row
- Closed at $99.96, +0.31% vs the prior close of $99.65. Day range $99.69–$100.07, opened at $99.78.
- Volume was 706.00K shares, 0.5x its 50-day average of 1.49M — lighter than usual.
- Price is -0.8% vs its 50-day average ($100.78) and +13.5% vs its 200-day average ($88.07).
- 52-week range $49.67–$111.86; today's close sits at 81% of that range, 10.6% below the 52-week high.
- That makes 3 straight gains.
- SEC filings that day: 8-K.
LNTH latest news & SEC filings
Every SEC filing by or about LNTH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · DEFA14A — Additional proxy materials
Additional proxy materials
Oct 2, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 23, 2026 · SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 21, 2026 · DEFA14A — Additional proxy materials
Additional proxy materials
Sep 21, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 17, 2026 · DEFA14A — Additional proxy materials
Additional proxy materials
Sep 8, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 4, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 4, 2026 · SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade LNTH
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 26, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.14% (largest 0.3%). That is a relatively calm stock.
- Liquidity: about 972.17K shares (≈$97.21M) trade per day on average.
- 52-week position: $99.99 vs a range of $50.15–$111.86 (81% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 2, 2026; 8-K Sep 21, 2026; 10-Q Aug 6, 2026.
- Share count: 65.27M shares outstanding (Aug 3, 2026), -4.0% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: In Vitro & In Vivo Diagnostic Substances.
LNTH market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 100.05 | 100.18 | 99.95 | 99.99 | 866.50K |
| Oct 14, 2026 | 100.06 | 100.23 | 99.92 | 100.00 | 936.70K |
| Oct 13, 2026 | 100.20 | 100.28 | 99.99 | 100.02 | 1.54M |
| Oct 12, 2026 | 100.10 | 100.36 | 100.06 | 100.11 | 951.60K |
| Oct 9, 2026 | 100.06 | 100.40 | 100.06 | 100.15 | 973.50K |
| Oct 8, 2026 | 100.08 | 100.33 | 100.08 | 100.12 | 520.10K |
| Oct 7, 2026 | 100.20 | 100.33 | 100.02 | 100.18 | 553.80K |
| Oct 6, 2026 | 100.28 | 100.34 | 99.89 | 99.95 | 730.10K |
| Oct 5, 2026 | 100.00 | 100.28 | 99.95 | 100.19 | 658.90K |
| Oct 2, 2026 | 99.78 | 100.07 | 99.69 | 99.96 | 706.00K |
| Oct 1, 2026 | 99.52 | 99.79 | 99.52 | 99.65 | 617.10K |
| Sep 30, 2026 | 99.55 | 99.74 | 99.31 | 99.53 | 1.81M |
| Sep 29, 2026 | 99.61 | 99.85 | 99.31 | 99.51 | 1.25M |
| Sep 28, 2026 | 99.68 | 99.96 | 99.61 | 99.74 | 1.25M |
| Sep 25, 2026 | 99.92 | 99.99 | 99.72 | 99.74 | 952.40K |
| Sep 24, 2026 | 100.00 | 100.02 | 99.69 | 99.72 | 938.50K |
| Sep 23, 2026 | 100.28 | 100.28 | 99.89 | 99.97 | 865.40K |
| Sep 22, 2026 | 100.28 | 100.40 | 99.98 | 100.00 | 1.52M |
| Sep 21, 2026 | 100.96 | 100.96 | 100.22 | 100.28 | 786.70K |
| Sep 18, 2026 | 100.79 | 100.96 | 100.48 | 100.55 | 1.03M |
About Lantheus
Lantheus (LNTH) is listed on the Nasdaq and classified by the SEC under “In Vitro & In Vivo Diagnostic Substances”. Its business address is in BEDFORD, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1521036.
LNTH board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Minnie Baylor-Henry | Director | May 18, 2026 |
| Gerard Ber | Director | Jun 3, 2026 |
| Julia Marie Eastland | Director | May 18, 2026 |
| Mary Anne Heino | Executive Chair and CEO | Jun 3, 2026 |
| Sam R Leno | Director | May 18, 2026 |
| Heinz Christoph Maeusli | Director | May 18, 2026 |
| Julie Mchugh | Director | May 18, 2026 |
| Phuong Khanh Morrow | Director | May 18, 2026 |
| Gary J Pruden | Director | May 18, 2026 |
| James H Thrall | Director | May 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kimberly Brown | Chief Accounting Officer | Aug 19, 2026 |
| Ludger Dinkelborg | See Remarks | Aug 19, 2026 |
| Mary Anne Heino | Executive Chair and CEO | Jun 3, 2026 |
| Robert J. Jr. Marshall | CFO and Treasurer | Sep 2, 2026 |
| Amanda Michelle Morgan | Chief Commercial Officer | Mar 9, 2026 |
| Daniel Niedzwiecki | See Remarks | Apr 21, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
LNTH financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.54B | $233.56M | 3.41 | $390.14M |
| Dec 31, 2024 | $1.53B | $312.44M | 4.36 | $544.75M |
| Dec 31, 2023 | $1.30B | $326.66M | 4.65 | $305.26M |
| Dec 31, 2022 | $935.06M | $28.07M | 0.40 | $281.78M |
| Dec 31, 2021 | $425.21M | $-71.28M | -1.06 | $53.92M |
Latest balance sheet: total assets $2.41B, total liabilities $1.10B, cash $593.30M (as of Jun 30, 2026).
LNTH earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $101.07 |
| May 7, 2026 | 8-K Item 2.02 (results) | $91.00 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $75.43 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $53.69 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $51.87 |
| May 7, 2025 | 8-K Item 2.02 (results) | $80.49 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $93.25 |
| Jan 28, 2025 | 8-K Item 2.02 (results) | $91.13 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $91.17 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 22, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · In Vitro & In Vivo Diagnostic Substances
Idexx Laboratories (IDXX)Intellia Therapeutics (NTLA)Neogen (NEOG)Celldex Therapeutics (CLDX)QuidelOrtho (QDEL)Achieve Life Sciences (ACHV)Myriad Genetics (MYGN)Alpha Teknova (TKNO)Insight Molecular Diagnostics (IMDX)Volitionrx (VNRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on LNTH
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.